Tag Archives: TB Alliance

47th Union World Conference on Lung Health: Soft drink company takes the challenge to build a new Pepsi generation

By on .

LIVERPOOL, England – People have a limited ability to taste sweet things. Cats, it turns out don’t have any. On the other hand, we humans have 22 taste receptors for bitterness. But all of that can be overcome by science. These are some of the things you learn when a company in the business of marketing […]

Childhood tuberculosis: Study finds larger global hidden epidemic

By on .

Indications of a  “huge undiagnosed reservoir” of pediatric tuberculosis, with actual incidence much higher than the number of cases reported highlight the need for additional study of the disease in children, and an opportunity for improved prevention through household screening, a study released in The Lancet today says. Authors of the study, produced by researchers […]

TB trial will test shorter, simpler regimen for drug-resistant and drug-sensitive disease

By on .

A clinical TB treatment trial announced Wednesday will show if a regimen of two new TB drug candidates and one that is part of existing tuberculosis treatment can streamline, shorten and greatly reduce costs of treatment for the disease, including some drug-resistant strains, significantly improving the odds that more patients will complete treatment successfully. The […]

Collaboration seeks to speed new TB treatments

By on .

About half a century has passed since a new tuberculosis drug was put to use, and in that time the challenges to successful treatment of the disease have only grown, with bacteria adapting faster to conditions that allowed it to flourish than science and funding for research. Morphing into forms that require from months to […]

Lancet Series Showcases Challenges, Promise in the Fight Against TB

By on .

Today, The Lancet launched an impressive new series of articles on the global tuberculosis epidemic, which claims 1.8 million lives every year. The Lancet articles note that TB is a leading cause of death in people in the most economically productive age-groups. The series highlights scale up of treatment and diagnoses, drug-resistant TB, and HIV/TB […]

Promising New TB Drugs Put on a Fast Track

By on .

This afternoon, Dr. Mel Spigelman, president and CEO of the Global Alliance for TB Drug Development, and other leading TB advocates will join with FDA Commissioner Margaret Hamburg to launch a new initiative designed to accelerate the development and approval of life-saving new treatments for tuberculosis. There are now at least 9 promising new TB […]